跳至主要内容
临床试验/NCT02074111
NCT02074111Unknown不适用

Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke

Samsung Medical Center1 个研究点 分布在 1 个国家目标入组 400 人开始时间: 2014年1月最近更新:
适应症

试验速览

阶段
不适用
入组人数
400
试验地点
1
主要终点
Frequency of RNF213 gene variants and HR-MRI findings in patients with intracranial atherosclerosis

研究概览

简要总结

The aim of this study is to investigate the proportion of patients with moyamoya disease among the patients who were diagnosed as having intracranial atherosclerotic stroke. To do this, biomarkers (gene and imaging) for moyamoya disease are tested and follow up angiography are performed during follow up (in selected patients).

详细描述

  1. Purpose Both moyamoya disease (MMD) and intracranial atherosclerotic stenosis (ICAS) are more prevalent in Asians than in Westerners, although the reason for the race-ethnic differences is unsettled. It is possible that patients with adult-onset MMD were misclassified as having ICAS, which may in part explain the high prevalence of intracranial atherosclerosis in Asians. It is important to differentiation between these two diseases because MMD and ICAS have differential therapeutic strategies (surgical revascularization in MMD vs. the use of antithrombotics/statins and stenting in ICAS). The ring finger 213 (RNF213) was recently identified as a susceptibility gene for MMD in East Asians. Characteristic high-resolution (HR) MRI findings of MMD and ICAS have recently been reported. The aim of this study is to investigate the proportion of patients with moyamoya disease among the patients who were diagnosed as having intracranial atherosclerotic stroke. To do this, biomarkers (gene and imaging) for moyamoya disease are tested and follow up angiography are performed during follow up (in selected patients).
  2. Conditions: Stroke, intracranial occlusive lesion
  3. Intervention: None
  4. Study period: Jan 22, 2014 ~ Dec 31, 2016
  5. Study design: Observational model Time perspective: Retrospective-Prospective

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Other

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Intracranial atherosclerotic stroke
  • Patients with age over 20 years
  • Patients with focal neurological deficits presented within 7 days of symptom onset
  • Patients with acute ischemic lesions on diffusion-weighted image (DWI)
  • Patients with stenosis on the relevant intracranial vessels (distal ICA and/ or M1)
  • Moyamoya disease
  • Patients with age over 20 years
  • Patients who performed conventional angiography
  • Patients who are diagnosed as having either definite or probable Moyamoya disease
  • Healthy subjects
  • Subjects with age over 20 years
  • Subjects with no history of cerebrovascular disease

排除标准

  • Patients with extracranial stenosis more than 50%
  • Patients with potential sources of cardio-aortic embolism
  • Patients with moderate to severe renal disease
  • Pregnancy or lactation
  • Patients with short life expectancy

结局指标

主要结局

Frequency of RNF213 gene variants and HR-MRI findings in patients with intracranial atherosclerosis

时间窗: Anytime during study period (in intracranial atherosclerosis, HR-MRI findings within 2 weeks)

次要结局

  • Frequency of typical angiographic findings of moyamoya disease at follow up conventional angiography in patients with intracranial atherosclerosis who showed typical gene and imaging biomarkers of moyamoya disease(Within 2 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Oh Young Bang

Associate Professor

Samsung Medical Center

研究点 (1)

Loading locations...

相似试验